全文获取类型
收费全文 | 1180篇 |
免费 | 82篇 |
国内免费 | 26篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 71篇 |
妇产科学 | 156篇 |
基础医学 | 113篇 |
口腔科学 | 36篇 |
临床医学 | 93篇 |
内科学 | 204篇 |
皮肤病学 | 19篇 |
神经病学 | 26篇 |
特种医学 | 134篇 |
外科学 | 153篇 |
综合类 | 77篇 |
预防医学 | 74篇 |
眼科学 | 17篇 |
药学 | 80篇 |
肿瘤学 | 32篇 |
出版年
2023年 | 11篇 |
2021年 | 6篇 |
2020年 | 5篇 |
2019年 | 8篇 |
2018年 | 16篇 |
2017年 | 8篇 |
2016年 | 11篇 |
2015年 | 19篇 |
2014年 | 23篇 |
2013年 | 42篇 |
2012年 | 40篇 |
2011年 | 35篇 |
2010年 | 48篇 |
2009年 | 55篇 |
2008年 | 55篇 |
2007年 | 63篇 |
2006年 | 63篇 |
2005年 | 42篇 |
2004年 | 52篇 |
2003年 | 43篇 |
2002年 | 30篇 |
2001年 | 23篇 |
2000年 | 24篇 |
1999年 | 23篇 |
1998年 | 38篇 |
1997年 | 38篇 |
1996年 | 42篇 |
1995年 | 26篇 |
1994年 | 19篇 |
1993年 | 25篇 |
1992年 | 19篇 |
1991年 | 21篇 |
1990年 | 25篇 |
1989年 | 39篇 |
1988年 | 26篇 |
1987年 | 30篇 |
1986年 | 30篇 |
1985年 | 21篇 |
1984年 | 16篇 |
1983年 | 11篇 |
1982年 | 8篇 |
1981年 | 5篇 |
1980年 | 14篇 |
1979年 | 18篇 |
1978年 | 7篇 |
1977年 | 7篇 |
1976年 | 9篇 |
1975年 | 5篇 |
1974年 | 9篇 |
1972年 | 6篇 |
排序方式: 共有1288条查询结果,搜索用时 46 毫秒
41.
42.
43.
44.
45.
46.
47.
Schofield A Hankins J Sutherland F 《HPB : the official journal of the International Hepato Pancreato Biliary Association》2003,5(4):261-263
BackgroundCholecystohepatic ducts are rare congenital variants of the biliary tree.Case outlineAn 81-year-old woman presented with biliary colic and elevated liver function tests. An ERCP demonstrated a common bile duct stone and stricture of the common hepatic duct. An operative cholangiogram demonstrated an atrophic common hepatic duct and retrograde filling of the gallbladder through a large cholecystoheptic duct. The patient had a cholecystectomy and reconstructive cholecystohepatic duct jejunostomy.DiscussionThis case demonstrates a rare congenital anomaly where the gallbladder fills retrograde during an intraoperative cholangiogram despite clipping of the cystic duct. The major path of biliary drainage was through a large cholecystoheptic duct similar to a gallbladder interposition; however, the common hepatic duct was still present but atrophic. This anomaly has not been described previously. 相似文献
48.
The activation of factor XI initiates the intrinsic coagulation pathway. Until recently it was believed that the main activator of factor XI is factor XIIa in conjunction with the cofactor high molecular weight kininogen on a negatively charged surface. Two recent reports have presented evidence that in a purified system factor XI is activatable by thrombin together with the soluble polyanion dextran sulfate. To assess the physiological relevance of these findings we studied the activation of factor XI in normal and factor XII-deficient plasma. We used either kaolin/cephalin or dextran sulfate as a surface for the intrinsic coagulation pathway, tissue factor to generate thrombin via the extrinsic pathway, or the addition of alpha-thrombin directly. 125I-factor XI, added to factor XI-deficient plasma at physiologic concentrations (35 nmol/L), is rapidly cleaved on incubation with kaolin. The kinetics appear to be exponential with half the maximum cleavage at 5 minutes. Similar kinetics of factor XI cleavage are seen when 40 nmol/L factor XIIa (equal to 10% of factor XII activation) is added to factor XII-deficient plasma if an activating surface is provided. Tissue factor (1:500) added to plasma did not induce cleavage of factor XI during a 90-minute incubation, although fibrin formation within 30 seconds indicated that thrombin was generated via the extrinsic pathway. Adding 1 mumol/L alpha-thrombin (equivalent to 50% prothrombin activation) directly to factor XII deficient or normal plasma (with or without kaolin/cephalin/Ca2+ or dextran sulfate) led to instantaneous fibrinogen cleavage, but again no cleavage of factor XI was observable. We conclude that in plasma surroundings factor XI is not activated by thrombin, and that proposals of thrombin initiation of the intrinsic coagulation cascade are not supportable. 相似文献
49.
50.
Goan SR; Fichtner I; Just U; Karawajew L; Schultze W; Krause KP; von Harsdorf S; von Schilling C; Herrmann F 《Blood》1995,86(1):89-100
Mononuclear cells (MNCs) containing peripheral blood stem cells (PBSCs) were obtained from solid-tumor patients undergoing mobilizing chemotherapy followed by granulocyte colony-stimulating factor for PBSC transplantation-supported dose-intensified anticancer chemotherapy and were transplanted into unconditioned "nonleaky" young severe combined immunodeficient mice. Multilineage engraftment was shown by flow cytometry and immunocytochemistry using monoclonal antibodies to various human cell surface antigens as well as identification of human immunoglobulin in murine sera. Within a dose range of MNCs suitable for transplantation (10 to 36 x 10(6) cells/graft) the number of CD34+ cells injected (optimal at > 0.7 x 10(6)/graft) determined the yield of human cells produced in recipient animals. Engraftment of hu PBSC preparations resulted in prolonged generation of physiologic levels of human cytokines including interleukin-3 (IL-3), IL-6, and granulocyte- macrophage colony-stimulating factor, which were detectable in the murine blood over a period of at least 4 months. In vivo survival of immature human progenitor cells was preserved even 9 months after transplantation. Because human IL-3 is known to stimulate early hematopoiesis, a rat fibroblast cell line was stably transfected with a retroviral vector carrying the human IL-3 gene and cotransplanted subcutaneously as additional source of growth factor. Cotransplants of this cell line producing sustained in vivo levels of circulating human IL-3 for at least 12 weeks significantly accelerated the process of engraftment of huPBSC and spurred the spread of mature human cells to the murine spleen, liver, thymus, and peripheral blood. Cotransplants of allogeneic human bone marrow stromal cells derived from long-term cultures resulted in a comparable--though less prominent--support of engraftment. 相似文献